World's Best Scientists 2026 revealed!
Manuela Bartolini

Manuela Bartolini

D-Index & Metrics

Chemistry

D-Index
61
Citations
11749
World Ranking
9352
National Ranking
273

Manuela Bartolini publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Manuela Bartolini sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 211 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Manuela Bartolini D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Manuela Bartolini sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 61 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Manuela Bartolini is affiliated with the University of Bologna in Italy and has a research focus spanning medicine, biochemistry, genetics, and molecular biology. The scientist's work intersects various subfields including pharmacology, molecular biology, computational theory and mathematics, complementary and alternative medicine, and physiology. Bartolini's research topics include cholinesterase and neurodegenerative diseases, computational drug discovery methods, medicinal plants and neuroprotection, Alzheimer's disease research and treatments, chemical synthesis and alkaloids, liver disease diagnosis and treatment, and DNA repair mechanisms.

Frequent coauthors in Bartolini's research include Marina Naldi, Daniele Tedesco, María Laura Bolognesi, Diego Muñoz-Torrero, and Ondřej Soukup.

The scientist has published extensively in several key journals:

  • Journal of Medicinal Chemistry (4 publications)
  • European Journal of Medicinal Chemistry (4 publications)
  • ACS Chemical Neuroscience (3 publications)
  • Molecules (3 publications)
  • Bioorganic Chemistry (2 publications)

Some of the notable recent papers include:

  • Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer's Disease, 2021, Journal of Medicinal Chemistry
  • Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice, 2020, Journal of Medicinal Chemistry
  • Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications, 2021, Hepatology
  • Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer's Disease, 2022, Journal of Medicinal Chemistry
  • N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study, 2020, Bioorganic Chemistry

Best Publications

  • β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies

    Manuela Bartolini;Carlo Bertucci;Vanni Cavrini;Vincenza Andrisano

  • Insight Into the Kinetic of Amyloid β (1–42) Peptide Self-Aggregation: Elucidation of Inhibitors’ Mechanism of Action

    Manuela Bartolini;Carlo Bertucci;Maria Laura Bolognesi;Andrea Cavalli

  • 3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation: A Dual Function Lead for Alzheimer's Disease Therapy§

    Lorna Piazzi;Angela Rampa;Alessandra Bisi;Silvia Gobbi

  • Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.

    Maria Laura Bolognesi;Andrea Cavalli;Luca Valgimigli;Manuela Bartolini

  • Rational approach to discover multipotent anti-Alzheimer drugs.

    Michela Rosini;Vincenza Andrisano;Manuela Bartolini;Maria L. Bolognesi

  • Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.

    Lorna Piazzi;Andrea Cavalli;Francesco Colizzi;Federica Belluti

  • Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.

    Pilar Munoz-Ruiz;Laura Rubio;Esther Garcia-Palomero;Isabel Dorronsoro

  • Novel Donepezil-Based Inhibitors of Acetyl- and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation

    Pelayo Camps;Xavier Formosa;Carles Galdeano;Tània Gómez

  • Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.

    Michela Rosini;Elena Simoni;Manuela Bartolini;Andrea Cavalli

  • Pyrano[3,2-c]quinoline−6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds

    Pelayo Camps;Xavier Formosa;Carles Galdeano;Diego Muñoz-Torrero

  • A small molecule targeting the multifactorial nature of Alzheimer's disease.

    Andrea Cavalli;Maria Laura Bolognesi;Simona Capsoni;Vincenza Andrisano

  • Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, β Amyloid Aggregation, and Aβ Neurotoxicity

    Stefano Rizzo;Céline Rivière;Lorna Piazzi;Alessandra Bisi

  • SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues

    Maurizio Recanatini;Andrea Cavalli;Federica Belluti;Lorna Piazzi

  • Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.

    José Marco-Contelles;Rafael León;Cristóbal de los Ríos;Abdelouahid Samadi

  • Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects

    Eugenie Nepovimova;Elisa Uliassi;Jan Korabecny;Luis Emiliano Peña-Altamira

  • Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease

    Maria Laura Bolognesi;Rita Banzi;Manuela Bartolini;Andrea Cavalli

  • Strategies for the Inhibition of Protein Aggregation in Human Diseases

    Manuela Bartolini;Vincenza Andrisano

  • Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.

    Maria Laura Bolognesi;Manuela Bartolini;Andrea Cavalli;Vincenza Andrisano

  • Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography.

    Xiaoming Zha;Doriano Lamba;Lili Zhang;Yinghan Lou

  • Propidium-Based Polyamine Ligands as Potent Inhibitors of Acetylcholinesterase and Acetylcholinesterase-Induced Amyloid-β Aggregation

    Maria Laura Bolognesi;Vincenza Andrisano;Manuela Bartolini;Rita Banzi

Frequent Co-Authors

Vincenza Andrisano
Vincenza Andrisano University of Bologna
Maria Laura Bolognesi
Maria Laura Bolognesi University of Bologna
Andrea Cavalli
Andrea Cavalli Italian Institute of Technology
Maurizio Recanatini
Maurizio Recanatini University of Bologna
Vanni Cavrini
Vanni Cavrini University of Bologna
José Marco-Contelles
José Marco-Contelles Spanish National Research Council
F. Javier Luque
F. Javier Luque University of Barcelona
Patrizia Hrelia
Patrizia Hrelia University of Bologna
Romana Fato
Romana Fato University of Bologna
Nibaldo C. Inestrosa
Nibaldo C. Inestrosa Pontificia Universidad Católica de Chile

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various online degrees and exciting career pathways. For those interested in complementing their scientific knowledge with legal expertise, pursuing a paralegal studies associate degree can provide valuable skills for roles involving regulatory compliance and patent law.

Alternatively, a Chemistry degree is a strong foundation for entering the pharmaceutical industry. Becoming a pharmaceutical representative offers opportunities to engage with healthcare providers and promote new medications. Understanding the pharmaceutical rep salary and typical career trajectory can help prospective students assess this path.

Those aiming for higher specialization might consider becoming a licensed pharmacist. This career requires thorough education and licensing but is highly rewarding both financially and professionally. Learn more about the pharmacist salary and necessary steps to enter the field.

Additionally, Chemistry graduates interested in forensic science can explore roles such as medical examiner assistants. This pathway combines analytical skills with investigative work; find details on how to become a medical examiner assistant, including the educational requirements and job outlook, at how to become a medical examiner assistant.

Best Scientists Citing Manuela Bartolini

Trending Scientists

Recently Published Articles